Last Price Today's Change   Day's Range   Trading Volume
0.745   +0.01 (1.36%)  0.715 - 0.745  199,000
Analyze this stock with MQ Trader system

Dividend, Bonus, Split & Consolidation

Hints :
[1] Click the View Entitlement icon table to view the Entitlement detail page.

Click here to modify the Visible Columns.

Ann. Date Ex Date Payment Date Type Subject Amount View
29-May-2019 14-Jun-2019 17-Jun-2019 BONUS_ISSUE Bonus Issue 1 : 3 Dividend Detail
29-Apr-2019 30-May-2019 14-Jun-2019 DIVIDEND First and Final Dividend RM 0.01 Dividend Detail
29-Apr-2019 30-May-2019 14-Jun-2019 DIVIDEND Special Dividend RM 0.005 Dividend Detail
28-Apr-2016 07-Jun-2016 08-Jul-2016 DIVIDEND Final Dividend RM 0.0040 Dividend Detail
24-May-2012 26-Jun-2012 18-Jul-2012 DIVIDEND First and Final Dividend RM 0.005 Dividend Detail
07-Jun-2005 28-Jul-2005 30-Aug-2005 DIVIDEND First and Final Dividend RM 0.005 Dividend Detail
12-Aug-2004 27-Aug-2004 01-Sep-2004 STOCK_SPLIT Others 10 : 1 Dividend Detail
07-Jul-2004 22-Jul-2004 26-Jul-2004 BONUS_ISSUE Bonus Issue 1 : 5 Dividend Detail
01-Jun-2004 28-Jun-2004 29-Jul-2004 DIVIDEND First and Final Dividend RM 0.05 Dividend Detail
05-Jun-2003 04-Jul-2003 28-Jul-2003 DIVIDEND Others RM 0.1 Dividend Detail
03-Jun-2002 26-Jun-2002 05-Jul-2002 DIVIDEND Special Dividend 5% Dividend Detail
03-Jun-2002 26-Jun-2002 05-Jul-2002 DIVIDEND Final Dividend 5% Dividend Detail
Trade this stock for as low as 0.05% brokerage. Find out more.

  5 people like this.
ZStrader yummy...
04/11/2019 2:35 PM
Ahmad Syafwan Yusoff is scomnet downtrend?
05/11/2019 1:06 PM
ZStrader yummy...
05/11/2019 2:43 PM
aspiral25 Uptrend stock with overbought status. Long term still consider good may hold. Short term go look other stock. Trader just study ta
06/11/2019 12:28 PM
BobLimm Another good news from one of their key customers. scomnet. Edward's Lifesciences Sapien 3 TAVI receiving approval for Europe market for low risk patients. Down stream suppliers confirm will benefit from this expanded market.

06/11/2019 4:33 PM
Huat1 Good profitable company with good track records. Expect the coming QR to be good too. Hold tight
15/11/2019 3:57 PM
Investar2862 Positive news for SCOMNET...

20/11/2019 5:22 AM
ZStrader QR next week... gg
21/11/2019 12:16 PM
Huat1 How possible?
21/11/2019 12:56 PM
LiimInvest Sure good
21/11/2019 11:22 PM
ZStrader time to buy.... yummy
22/11/2019 8:41 AM
ZStrader go fly
22/11/2019 9:48 AM
t_nike2002 Still overpriced... all future profits already built into the current price already....If results not good then it will tumble badly...
26/11/2019 11:31 AM
tracker113 still continue drop
26/11/2019 3:46 PM
ZStrader end story... just wait QR out... otherwise burn lor...
26/11/2019 7:55 PM
dasm1284 next QR should be good as their major customer Edward Life sciences is doing well. their share price is near record high
27/11/2019 8:13 AM
27/11/2019 1:45 PM
tracker113 Result out. Rev record highest... but profit decrease
27/11/2019 5:58 PM
BobLimm For the period under review , Group revenue has been increased by 48.28% (or RM29.49 million) from RM 61.08 million to RM 90.57 million whereby Supercomal Medical Product(SMP) contribute 20.61 million of the sales increment. The profit after tax increased by 40.44 % ( or RM 4.11 million) from RM 10.15 million to RM 14.26 million after the amortisation of RM 3 million intangible assets. The improvement in profit mainly due to contribution from SMP which accounted 80% of profit for the period .

Medical business is contributing 2/3 of the revenue growth.
27/11/2019 6:24 PM
BobLimm If not for RM3mil amortization, profit would have been RM17mil
27/11/2019 6:26 PM
dasm1284 @BobLimm no worries. SMP should drive the revenue going forward
27/11/2019 8:48 PM
Investar2862 Stock price should be better from now...
28/11/2019 8:57 AM
tracker113 this stock gg liao
29/11/2019 10:40 AM
Excommunicado Being the person who is directly involved in Sapien 3 valve by Edwards Lifesciences , it's the only valve in the world that has direct competition with the valve by medtronic. The Asian penetration of this valve is still at the beginning stage, but soon we will see an increase in the usage of sapien 3. The only downside is the vale costs about 100k. However, it's been widely used in European countries. What I can see is the revenue for it will continue to grow in near future because of the new research paper on the usage of the valve named Partner III trial. Hence, it's quite a safe assumption that the revenue will keep growing from the medical side.
02/12/2019 11:10 PM
tracker113 gone... no buyer at all
04/12/2019 4:25 PM
ZStrader just wait when it turn... hohooo
04/12/2019 9:21 PM
dasm1284 Ho Ho Ho
05/12/2019 8:45 AM
LiimInvest Impossible
08/12/2019 6:32 PM
dasm1284 I agree with @LiimInvest. this stock is a growth story
09/12/2019 8:46 AM
tracker113 good stock also down
13/12/2019 10:32 AM
Huat1 Immediate support at 0.72.
Already Oversold !!!
Time to rebound
15/12/2019 7:27 PM
runroadtokl TA show is time to rebound
17/12/2019 5:00 PM
LiimInvest Yu_and_Mee@ hahaha impossible. TP over RM 1.00
17/12/2019 6:43 PM
Investar2862 Congratulation!

You got your charting right...

Posted by Huat1 > Dec 15, 2019 7:27 PM | Report Abuse

Immediate support at 0.72.
Already Oversold !!!
Time to rebound
18/12/2019 11:06 AM
dasm1284 impossible. this is a potentially RM1 stock.
18/12/2019 11:07 AM
dasm1284 huat1 master of charts , hehe
18/12/2019 11:30 AM
t_nike2002 PE 29x wake up....
26/12/2019 4:38 PM
BobLimm Coming up

04/01/2020 4:16 PM
07/01/2020 10:32 AM
LiimInvest Medical devices products
28/01/2020 10:54 PM
LiimInvest Technical Buy - SCOMNET-WA (0001WA) - PublicInvest Research | I3investor
Sign In

PublicInvest Research click to expand contents
Technical Buy - SCOMNET-WA (0001WA)
Author: PublicInvest Publish date: Wed, 29 Jan 2020, 6:11 PM

Target Price: RM0.535, RM0.590
Last closing price: RM0.490
Potential return: 9.1%, 20.4%
Support: RM0.440
Stop Loss: RM0.425
Possible for further upside. SCOMNET-WA rebounded off its key support level. Improving RSI and MACD indicators currently signal reasonable entry level, with anticipation of continuous improvement in both momentum and trend in near term. Should resistance level of RM0.515 be broken, it may continue to lift price higher to subsequent resistance levels of RM0.535 and RM0.590. Note that the maturity date of SCOMNET-WA is on 19 June 2024.

However, failure to hold on to support level of RM0.440 may indicate weakness in the share price and hence, a cut-loss signal

Source: PublicInvest Research - 29 Jan 2020
29/01/2020 9:18 PM
BobLimm Key customers earning reporting, sales grew 20%

31/01/2020 6:28 AM
LiimInvest Good news
03/02/2020 4:59 PM
BobLimm 80% of raw material cost of cable wire is copper. Copper price has been tumbling down for the past months from USD6300 to 5500/ton and it is still coming down. For sure this lower raw material cost will boost their margin.
04/02/2020 11:43 AM
vcheekeong disappointed
21/02/2020 7:06 PM
LiimInvest Heard coming QR is good
21/02/2020 9:57 PM
stressedesserts Signficant Revenue Growth Factors:
1. Major Clients: Edward Lifesciences + Ambu both had huge sales growth
Edward Lifesciences:
• Q4 TAVR1 sales grew 29%; underlying sales grew 30%
• SAPIEN 3 transcatheter heart valve received expansion in Europe
2. Edward Lifesciences received FDA approval for 2 transcatheter heart valve systems
2. Medical sector growth
3. Malaysia Budget 2020: RM227M for upgrading medical equipment
4. Edwards Lifesciences Ltd set up its second regional business hub in KL
5. Copper price stayed low in Q4 2019
22/02/2020 11:29 PM
dasm1284 thanks @Stressedesserts for the catalysts above. be patient to loyal shareholders : )
23/02/2020 2:29 PM
LiimInvest Global Demand for Medical devices is increasingly
23/02/2020 6:10 PM
dasm1284 QR incoming!
25/02/2020 4:16 PM


715  145  465  678 

Top 10 Active Counters
 XOX 0.06+0.01 
 AVI 0.16+0.005 
 SAPNRG 0.225-0.005 
 HSI-C7V 0.265+0.01 
 DGB 0.055+0.01 
 MYEG 1.23+0.01 
 MTOUCHE 0.160.00 
 XDL 0.1650.00 
 KRONO 0.765-0.055 
 PWRWELL 0.375+0.02 
Partners & Brokers